Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition. Dzama MM, Steiner M, Rausch J, Sasca D, et al. Blood 2020;136:2442-2456.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dzama MM, Steiner M, Rausch J, Sasca D, et al. Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition. Blood 2020;136:2442-2456.
PMID: 32589720